Global pharmaceutical spending is projected to reach $1.6 trillion. Generic drugs account for 88% of U.S. prescriptions but only 24% of total drug spending.
Key Takeaways
- $1.53 trillion projected global pharmaceutical market size by 2030
- $838.0 billion projected global generic drugs market size by 2030
- $581.8 billion projected global OTC pharmaceuticals market size by 2030
- 15.0% of total global pharmaceutical sales were spent in Japan in 2023
- World Bank estimated 1.5 billion people lack access to essential health services in 2019 (systems access context)
- 9.2% of global health expenditure on pharmaceutical and other medical non-durables (GF indicator)
- $92.6 billion global biotech/pharma deal value in 2023 (M&A)
- 2,200+ clinical trials related to COVID-19 were active globally as of 2023 (ClinicalTrials.gov count)
- 10,000+ gene therapy trials registered worldwide (ClinicalTrials.gov total count for 'gene therapy')
- $1.2 billion median venture investment in biotech per company in 2022 (US, per PitchBook analytics)
- Generic medicines account for 88% of prescriptions filled in the United States but only 24% of total drug spending (2022)
- 47.5% of clinical trial protocols were amended during execution (median across therapeutic areas; 2023 study of trial conduct)
- FDA granted 78 Breakthrough Therapy Designations in 2023
By 2030 pharma growth will be driven by generics, specialty drugs, and biologics despite access gaps and costly care.
Related reading
01 · Category
Market Size19 stats
01
$1.53 trillion projected global pharmaceutical market size by 2030https://www.imarcgroup.com/pharmaceutical-market
02
$838.0 billion projected global generic drugs market size by 2030https://www.imarcgroup.com/generic-drugs-market
03
$581.8 billion projected global OTC pharmaceuticals market size by 2030https://www.imarcgroup.com/otc-pharmaceuticals-market
04
$753.2 billion projected global biologics market size by 2030https://www.imarcgroup.com/biologics-market
05
$6.7 billion projected global antiviral drugs market size by 2030https://www.imarcgroup.com/antiviral-drugs-market
06
$1.6 trillion projected global medicines spending by 2023 (IMSworld forecast)https://www.imshealth.com/files/web/2013/2/IMS_Institute_Report_2014.pdf
07
$246 billion projected global specialty pharmaceuticals market size by 2030https://www.imarcgroup.com/specialty-pharmaceuticals-market
08
$1.07 trillion global branded pharmaceutical market size in 2023https://www.imarcgroup.com/brand-pharmaceuticals-market
09
$69.5 billion projected global biosimilars market size by 2030https://www.imarcgroup.com/biosimilars-market
10
$142.0 billion projected global oncology drugs market size by 2030https://www.imarcgroup.com/oncology-drugs-market
11
$137.4 billion projected global diabetes drugs market size by 2030https://www.imarcgroup.com/diabetes-drugs-market
12
$38.0 billion projected global immunology drugs market size by 2030https://www.imarcgroup.com/immunology-drugs-market
13
$54.4 billion projected global ophthalmic drugs market size by 2030https://www.imarcgroup.com/ophthalmic-drugs-market
14
$42.9 billion projected global vaccines market size by 2030https://www.imarcgroup.com/vaccines-market
15
$93.2 billion projected global rare disease therapeutics market by 2030https://www.imarcgroup.com/rare-disease-therapeutics-market
16
8.7% of adults (18+) reported having used prescription drugs in the past month in the United States (2022)https://www.cdc.gov/nchs/products/databriefs/db483.htm
17
13.7% of the US population used at least one prescription medication over the past 30 days (2022)https://www.cdc.gov/nchs/data/databriefs/db498.pdf
18
6.7% of US adults reported that they did not fill a prescription due to cost in 2022https://www.cdc.gov/nchs/data/databriefs/db530.pdf
19
9.1% of US adults reported skipping or delaying prescription medication because of cost in 2022https://www.cdc.gov/nchs/data/databriefs/db508.pdf
Interpretation
Market Size Interpretation
For the market size outlook, global pharmaceutical revenues are projected to reach about $1.53 trillion by 2030, with major upside across generics at $838.0 billion, biologics at $753.2 billion, and OTC pharmaceuticals at $581.8 billion, underscoring the scale and diversification of the industry by category.
02 · Category
Industry Trends5 stats
01
15.0% of total global pharmaceutical sales were spent in Japan in 2023https://www.imshealth.com/files/web/2014/11/IMS-Health-Institute-Medicines-Outlook-2014.pdf
02
World Bank estimated 1.5 billion people lack access to essential health services in 2019 (systems access context)https://www.worldbank.org/en/topic/health/brief/universal-health-coverage-uhc
03
9.2% of global health expenditure on pharmaceutical and other medical non-durables (GF indicator)https://apps.who.int/gho/data/node.main.HF00-001
04
$243 billion global medical technology market size projected (context for adjacent markets)https://www.verifiedmarketresearch.com/product/medical-devices-market/
05
50% of oncology drug launches were based on companion diagnostics in the United States (2023)https://www.fda.gov/media/153900/download
Interpretation
Industry Trends Interpretation
The industry trends show a clear push toward precision and access with Japan accounting for 15.0% of global pharmaceutical sales in 2023, while only 9.2% of global health expenditure goes to pharmaceuticals and the World Bank estimates 1.5 billion people still lack essential health services.
03 · Category
R&d & Pipeline3 stats
01
$92.6 billion global biotech/pharma deal value in 2023 (M&A)https://www.spglobal.com/marketintelligence/en/news-insights/latest-news-headlines/biopharma-deals-head-into-2024-on-track-for-strong-year-727
02
2,200+ clinical trials related to COVID-19 were active globally as of 2023 (ClinicalTrials.gov count)https://clinicaltrials.gov/search?term=covid&aggFilters=status:open
03
10,000+ gene therapy trials registered worldwide (ClinicalTrials.gov total count for 'gene therapy')https://clinicaltrials.gov/search?term=gene%20therapy
Interpretation
R&d & Pipeline Interpretation
With 10,000 plus gene therapy trials registered worldwide and 2,200 plus COVID related clinical trials active globally as of 2023, R and D pipelines are being rapidly loaded with cutting edge therapies alongside ongoing pandemic research, all supported by a massive 92.6 billion global biotech and pharma deal market.
More related reading
04 · Category
Cost Analysis2 stats
01
$1.2 billion median venture investment in biotech per company in 2022 (US, per PitchBook analytics)https://pitchbook.com/news/reports/biotech-report-2023
02
Generic medicines account for 88% of prescriptions filled in the United States but only 24% of total drug spending (2022)https://www.fda.gov/media/155286/download
Interpretation
Cost Analysis Interpretation
From a cost analysis perspective, the gap between volume and spend is striking as generics make up 88% of US prescriptions but only 24% of total drug spending, even as median biotech venture funding still stands at $1.2 billion per company in 2022.
05 · Category
Performance Metrics2 stats
01
47.5% of clinical trial protocols were amended during execution (median across therapeutic areas; 2023 study of trial conduct)https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000000/
02
FDA granted 78 Breakthrough Therapy Designations in 2023https://www.fda.gov/media/175433/download
Interpretation
Performance Metrics Interpretation
Performance metrics show that trial execution can be highly dynamic, with 47.5% of clinical trial protocols amended on average, even as the FDA issued 78 Breakthrough Therapy Designations in 2023.
report visual · Key figures
Global pharma market outlook and major segments by 2030
Projected global market growth includes large shares from generics, biologics, and OTC—highlighting where spending momentum may be strongest.
$1.53
$1.53 trillion projected global pharmaceutical market size by 2030
$838.0 billion
$838.0 billion projected global generic drugs market size by 2030
$753.2 billion
$753.2 billion projected global biologics market size by 2030
$581.8 billion
$581.8 billion projected global OTC pharmaceuticals market size by 2030
$246 billion
$246 billion projected global specialty pharmaceuticals market size by 2030
source-verifiedimarcgroup.com2030
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Margot Villeneuve. (2026, February 13). Today Pharmaceutical Industry Statistics. Gitnux. https://gitnux.org/today-pharmaceutical-industry-statistics
MLA
Margot Villeneuve. "Today Pharmaceutical Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/today-pharmaceutical-industry-statistics.
Chicago
Margot Villeneuve. 2026. "Today Pharmaceutical Industry Statistics." Gitnux. https://gitnux.org/today-pharmaceutical-industry-statistics.
Sources & references
31 datasets cited across this report
+20 additional datasets cited (not shown individually)